Loading…
Structural insight into the ligand-receptor interaction between glycyrrhetinic acid (GA) and the high-mobility group protein B1 (HMGB1)-DNA complex
Structural analysis of the high-mobility group protein B1 (HMGB1)-DNA complex and a docking simulation between glycyrrhetinic acid (GA) and the HMGB1-DNA complex were performed with a software package the Molecular Operating Environment (MOE). An HMGB1-DNA (PDB code: 2GZK) was selected for the 3D st...
Saved in:
Published in: | Bioinformation 2012-01, Vol.8 (23), p.1147-1153 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c353t-3eccaa5f8f975fa477d610ce3a904d66e32bc16e0c00d73480c8d8b51d9193143 |
---|---|
cites | |
container_end_page | 1153 |
container_issue | 23 |
container_start_page | 1147 |
container_title | Bioinformation |
container_volume | 8 |
creator | Yamaguchi, Hideaki Kidachi, Yumi Kamiie, Katsuyoshi Noshita, Toshiro Umetsu, Hironori |
description | Structural analysis of the high-mobility group protein B1 (HMGB1)-DNA complex and a docking simulation between glycyrrhetinic acid (GA) and the HMGB1-DNA complex were performed with a software package the Molecular Operating Environment (MOE). An HMGB1-DNA (PDB code: 2GZK) was selected for the 3D structure modeling of the HMGB1-DNA complex. The Site Finder module of the MOE identified 16 possible ligand-binding sites in the modeled HMGB1-DNA complex. The docking simulation revealed that GA possibly inhibits functions of HMGB1 interfering with Lys(90), Arg(91), Ser(101), Tyr(149), C(230) and C(231) in the HMGB1-DNA complex. To the best of our knowledge, this is the first report of an HMGB1-DNA complex with GA, and our data verify that the GA-HMGB1-DNA model can be utilized for application to target HMGB1 for the development of antitumor drugs.
ASE-Dock - alpha sphere and excluded volume-based ligand-protein docking, CNS - central nervous system, GA - glycyrrhetinic acid, GL - glycyrrhizin, HMGB1 - high-mobility group protein B1, LBS - ligand-biding site, MOE - Molecular Operating Environment, SRY - sex-determining region on the Y chromosome. |
doi_str_mv | 10.6026/97320630081147 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3530883</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1273147484</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-3eccaa5f8f975fa477d610ce3a904d66e32bc16e0c00d73480c8d8b51d9193143</originalsourceid><addsrcrecordid>eNqFkUFv1DAQhS0EoqVw5Yh83B5SPHESJxekbYEtUoEDcLYcZ5IYJXawncL-Dv4wXlqq9sRprJk3n5_9CHkJ7KxiefW6ETxnFWesBijEI3LMUic7tB7fOx-RZyF8Z6wAIcqn5CjnuSgFwDH5_SX6VcfVq4kaG8wwxlSjo3FEOplB2S7zqHGJzh8G6JWOxlnaYvyJaOkw7fXe-xGjsUZTpU1HN7vtKU2bfyFjYmaza81k4p4O3q0LXbyLaCw9B7q5_Lg7h9Ps7act1W5eJvz1nDzp1RTwxW09Id_ev_t6cZldfd59uNheZZqXPGYctVaq7Ou-EWWvCiG6CphGrhpWdFWFPG81VMg0Y53gRc103dVtCV0DDYeCn5A3N9xlbWfsNNqYvkEu3szK76VTRj6cWDPKwV3LdD2ra54Am1uAdz9WDFHOJmicJmXRrUECh7KCnAvxf2kukiVR1AdbZzdS7V0IHvs7R8DkIXT5MPS08Or-O-7k_1LmfwBBlahr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1273147484</pqid></control><display><type>article</type><title>Structural insight into the ligand-receptor interaction between glycyrrhetinic acid (GA) and the high-mobility group protein B1 (HMGB1)-DNA complex</title><source>PubMed Central</source><creator>Yamaguchi, Hideaki ; Kidachi, Yumi ; Kamiie, Katsuyoshi ; Noshita, Toshiro ; Umetsu, Hironori</creator><contributor>Kangueane, P</contributor><creatorcontrib>Yamaguchi, Hideaki ; Kidachi, Yumi ; Kamiie, Katsuyoshi ; Noshita, Toshiro ; Umetsu, Hironori ; Department of Pharmacy, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tenpaku, Nagoya 468-8503, Japan ; Kangueane, P</creatorcontrib><description>Structural analysis of the high-mobility group protein B1 (HMGB1)-DNA complex and a docking simulation between glycyrrhetinic acid (GA) and the HMGB1-DNA complex were performed with a software package the Molecular Operating Environment (MOE). An HMGB1-DNA (PDB code: 2GZK) was selected for the 3D structure modeling of the HMGB1-DNA complex. The Site Finder module of the MOE identified 16 possible ligand-binding sites in the modeled HMGB1-DNA complex. The docking simulation revealed that GA possibly inhibits functions of HMGB1 interfering with Lys(90), Arg(91), Ser(101), Tyr(149), C(230) and C(231) in the HMGB1-DNA complex. To the best of our knowledge, this is the first report of an HMGB1-DNA complex with GA, and our data verify that the GA-HMGB1-DNA model can be utilized for application to target HMGB1 for the development of antitumor drugs.
ASE-Dock - alpha sphere and excluded volume-based ligand-protein docking, CNS - central nervous system, GA - glycyrrhetinic acid, GL - glycyrrhizin, HMGB1 - high-mobility group protein B1, LBS - ligand-biding site, MOE - Molecular Operating Environment, SRY - sex-determining region on the Y chromosome.</description><identifier>ISSN: 0973-2063</identifier><identifier>ISSN: 0973-8894</identifier><identifier>EISSN: 0973-2063</identifier><identifier>DOI: 10.6026/97320630081147</identifier><identifier>PMID: 23275711</identifier><language>eng</language><publisher>Singapore: Biomedical Informatics</publisher><subject>Hypothesis</subject><ispartof>Bioinformation, 2012-01, Vol.8 (23), p.1147-1153</ispartof><rights>2012 Biomedical Informatics 2012</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-3eccaa5f8f975fa477d610ce3a904d66e32bc16e0c00d73480c8d8b51d9193143</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530883/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530883/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23275711$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Kangueane, P</contributor><creatorcontrib>Yamaguchi, Hideaki</creatorcontrib><creatorcontrib>Kidachi, Yumi</creatorcontrib><creatorcontrib>Kamiie, Katsuyoshi</creatorcontrib><creatorcontrib>Noshita, Toshiro</creatorcontrib><creatorcontrib>Umetsu, Hironori</creatorcontrib><creatorcontrib>Department of Pharmacy, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tenpaku, Nagoya 468-8503, Japan</creatorcontrib><title>Structural insight into the ligand-receptor interaction between glycyrrhetinic acid (GA) and the high-mobility group protein B1 (HMGB1)-DNA complex</title><title>Bioinformation</title><addtitle>Bioinformation</addtitle><description>Structural analysis of the high-mobility group protein B1 (HMGB1)-DNA complex and a docking simulation between glycyrrhetinic acid (GA) and the HMGB1-DNA complex were performed with a software package the Molecular Operating Environment (MOE). An HMGB1-DNA (PDB code: 2GZK) was selected for the 3D structure modeling of the HMGB1-DNA complex. The Site Finder module of the MOE identified 16 possible ligand-binding sites in the modeled HMGB1-DNA complex. The docking simulation revealed that GA possibly inhibits functions of HMGB1 interfering with Lys(90), Arg(91), Ser(101), Tyr(149), C(230) and C(231) in the HMGB1-DNA complex. To the best of our knowledge, this is the first report of an HMGB1-DNA complex with GA, and our data verify that the GA-HMGB1-DNA model can be utilized for application to target HMGB1 for the development of antitumor drugs.
ASE-Dock - alpha sphere and excluded volume-based ligand-protein docking, CNS - central nervous system, GA - glycyrrhetinic acid, GL - glycyrrhizin, HMGB1 - high-mobility group protein B1, LBS - ligand-biding site, MOE - Molecular Operating Environment, SRY - sex-determining region on the Y chromosome.</description><subject>Hypothesis</subject><issn>0973-2063</issn><issn>0973-8894</issn><issn>0973-2063</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqFkUFv1DAQhS0EoqVw5Yh83B5SPHESJxekbYEtUoEDcLYcZ5IYJXawncL-Dv4wXlqq9sRprJk3n5_9CHkJ7KxiefW6ETxnFWesBijEI3LMUic7tB7fOx-RZyF8Z6wAIcqn5CjnuSgFwDH5_SX6VcfVq4kaG8wwxlSjo3FEOplB2S7zqHGJzh8G6JWOxlnaYvyJaOkw7fXe-xGjsUZTpU1HN7vtKU2bfyFjYmaza81k4p4O3q0LXbyLaCw9B7q5_Lg7h9Ps7act1W5eJvz1nDzp1RTwxW09Id_ev_t6cZldfd59uNheZZqXPGYctVaq7Ou-EWWvCiG6CphGrhpWdFWFPG81VMg0Y53gRc103dVtCV0DDYeCn5A3N9xlbWfsNNqYvkEu3szK76VTRj6cWDPKwV3LdD2ra54Am1uAdz9WDFHOJmicJmXRrUECh7KCnAvxf2kukiVR1AdbZzdS7V0IHvs7R8DkIXT5MPS08Or-O-7k_1LmfwBBlahr</recordid><startdate>20120101</startdate><enddate>20120101</enddate><creator>Yamaguchi, Hideaki</creator><creator>Kidachi, Yumi</creator><creator>Kamiie, Katsuyoshi</creator><creator>Noshita, Toshiro</creator><creator>Umetsu, Hironori</creator><general>Biomedical Informatics</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20120101</creationdate><title>Structural insight into the ligand-receptor interaction between glycyrrhetinic acid (GA) and the high-mobility group protein B1 (HMGB1)-DNA complex</title><author>Yamaguchi, Hideaki ; Kidachi, Yumi ; Kamiie, Katsuyoshi ; Noshita, Toshiro ; Umetsu, Hironori</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-3eccaa5f8f975fa477d610ce3a904d66e32bc16e0c00d73480c8d8b51d9193143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Hypothesis</topic><toplevel>online_resources</toplevel><creatorcontrib>Yamaguchi, Hideaki</creatorcontrib><creatorcontrib>Kidachi, Yumi</creatorcontrib><creatorcontrib>Kamiie, Katsuyoshi</creatorcontrib><creatorcontrib>Noshita, Toshiro</creatorcontrib><creatorcontrib>Umetsu, Hironori</creatorcontrib><creatorcontrib>Department of Pharmacy, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tenpaku, Nagoya 468-8503, Japan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bioinformation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamaguchi, Hideaki</au><au>Kidachi, Yumi</au><au>Kamiie, Katsuyoshi</au><au>Noshita, Toshiro</au><au>Umetsu, Hironori</au><au>Kangueane, P</au><aucorp>Department of Pharmacy, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tenpaku, Nagoya 468-8503, Japan</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structural insight into the ligand-receptor interaction between glycyrrhetinic acid (GA) and the high-mobility group protein B1 (HMGB1)-DNA complex</atitle><jtitle>Bioinformation</jtitle><addtitle>Bioinformation</addtitle><date>2012-01-01</date><risdate>2012</risdate><volume>8</volume><issue>23</issue><spage>1147</spage><epage>1153</epage><pages>1147-1153</pages><issn>0973-2063</issn><issn>0973-8894</issn><eissn>0973-2063</eissn><abstract>Structural analysis of the high-mobility group protein B1 (HMGB1)-DNA complex and a docking simulation between glycyrrhetinic acid (GA) and the HMGB1-DNA complex were performed with a software package the Molecular Operating Environment (MOE). An HMGB1-DNA (PDB code: 2GZK) was selected for the 3D structure modeling of the HMGB1-DNA complex. The Site Finder module of the MOE identified 16 possible ligand-binding sites in the modeled HMGB1-DNA complex. The docking simulation revealed that GA possibly inhibits functions of HMGB1 interfering with Lys(90), Arg(91), Ser(101), Tyr(149), C(230) and C(231) in the HMGB1-DNA complex. To the best of our knowledge, this is the first report of an HMGB1-DNA complex with GA, and our data verify that the GA-HMGB1-DNA model can be utilized for application to target HMGB1 for the development of antitumor drugs.
ASE-Dock - alpha sphere and excluded volume-based ligand-protein docking, CNS - central nervous system, GA - glycyrrhetinic acid, GL - glycyrrhizin, HMGB1 - high-mobility group protein B1, LBS - ligand-biding site, MOE - Molecular Operating Environment, SRY - sex-determining region on the Y chromosome.</abstract><cop>Singapore</cop><pub>Biomedical Informatics</pub><pmid>23275711</pmid><doi>10.6026/97320630081147</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0973-2063 |
ispartof | Bioinformation, 2012-01, Vol.8 (23), p.1147-1153 |
issn | 0973-2063 0973-8894 0973-2063 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3530883 |
source | PubMed Central |
subjects | Hypothesis |
title | Structural insight into the ligand-receptor interaction between glycyrrhetinic acid (GA) and the high-mobility group protein B1 (HMGB1)-DNA complex |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A35%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structural%20insight%20into%20the%20ligand-receptor%20interaction%20between%20glycyrrhetinic%20acid%20(GA)%20and%20the%20high-mobility%20group%20protein%20B1%20(HMGB1)-DNA%20complex&rft.jtitle=Bioinformation&rft.au=Yamaguchi,%20Hideaki&rft.aucorp=Department%20of%20Pharmacy,%20Faculty%20of%20Pharmacy,%20Meijo%20University,%20150%20Yagotoyama,%20Tenpaku,%20Nagoya%20468-8503,%20Japan&rft.date=2012-01-01&rft.volume=8&rft.issue=23&rft.spage=1147&rft.epage=1153&rft.pages=1147-1153&rft.issn=0973-2063&rft.eissn=0973-2063&rft_id=info:doi/10.6026/97320630081147&rft_dat=%3Cproquest_pubme%3E1273147484%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c353t-3eccaa5f8f975fa477d610ce3a904d66e32bc16e0c00d73480c8d8b51d9193143%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1273147484&rft_id=info:pmid/23275711&rfr_iscdi=true |